Top

Gepubliceerd in:

2009 | OriginalPaper | Hoofdstuk

26 Corticobasale degeneratie

Auteurs : J.J. de Vries, K.L. Leenders

Gepubliceerd in: Handboek dementie

Uitgeverij: Bohn Stafleu van Loghum

Kernpunten

Corticobasale degeneratie is een zeldzame neurodegeneratieve aandoening gekenmerkt door een opmerkelijk asymmetrisch akinetisch-rigide syndroom met hogere corticale functiestoornissen (bijvoorbeeld apraxie, dysfasie, agrafesthesie).
Verschillende nosologische entiteiten kunnen aanleiding geven tot een corticobasaal syndroom.
Opvallend asymmetrische cerebrale atrofie en hypometabolisme contralateraal aan de klinisch meest aangedane zijde en asymmetrische vertraging van het EEGpatroon kan de diagnose ondersteunen.
Een curatieve behandeling ontbreekt en ook effectieve, symptomatische behandelingen zijn niet of nauwelijks voor CBD voorhanden.

vorige hoofdstuk 25 Progressieve supranucleaire verlamming

Ay H, Buonanno FS, Price BH, et al. Sensory alien hand syndrome: case report and review of the literature. J Neurol Neurosurg Psychiatry. 1998;65(3):366-9.

Blin J, Vidailhet MJ, Pillon B, et al. Corticobasal degeneration: decreased and asymmetrical glucose consumption as studied with PET. Mov Disord. 1992;7(4):348-54.

Boeve BF, Lang AE, Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann Neurol. 2003;54 Suppl 5:S15-9.

Boxer AL, Geschwind MD, Belfor N, et al. Patterns of Brain Atrophy That Differentiate Corticobasal Degeneration Syndrome From Progressive Supranuclear Palsy. Arch Neurol. 2006;63(1):81-6.

Brettschneider J, Petzold A, Sussmuth SD, et al. Neurofilament heavy-chain NfH(SMI35) in cerebrospinal fluid supports the differential diagnosis of Parkinsonian syndromes. Mov Disord. 2006;21(12):2224-7.

Dickson DW, Bergeron C, Chin SS, et al. Office of Rare Diseases neuropathologic criteria for corticobasal degeneration. J Neuropathol Exp Neurol. 2002;61(11):935-46.

Doi T, Iwasa K, Makifuchi T, et al. White matter hyperintensities on MRI in a patient with corticobasal degeneration. Acta Neurol Scand. 1999;99(3):199-201.

Eckert T, Barnes A, Dhawan V, et al. FDG PET in the differential diagnosis of parkinsonian disorders. NeuroImage. 2005;26(3):912-21.

Houlden H, Baker M, Morris HR, et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology. 2001;56(12):1702-6.

Josephs KA, Whitwell JL, Dickson DW, et al. Voxel-based morphometry in autopsy proven PSP and CBD. Neurobiology of Aging. 2008;29(2):280-9.

Kompoliti K, Goetz CG, Boeve BF, et al. Clinical presentation and pharmacological therapy in corticobasal degeneration. Arch Neurol. 1998;55(7):957-61.

Koyama M, Yagishita A, Nakata Y, et al. Imaging of corticobasal degeneration syndrome. Neuroradiology. 2007;49(11):905-12.

Litvan I, Cummings JL, Mega M. Neuropsychiatric features of corticobasal degeneration. J Neurol Neurosurg Psychiatry. 1998;65(5):717-21.

Monza D, Ciano C, Scaioli V, et al. Neurophysiological features in relation to clinical signs in clinically diagnosed corticobasal degeneration. Neurol Sci. 2003;24(1):16-23.

Nagahama Y, Fukuyama H, Turjanski N, et al. Cerebral glucose metabolism in corticobasal degeneration: comparison with progressive supranuclear palsy and normal controls. Mov Disord. 1997;12(5):691-6.

Okuda B, Tachibana H, Takeda M, et al. Asymmetric changes in somatosensory evoked potentials correlate with limb apraxia in corticobasal degeneration. Acta Neurol Scand. 1998;97(6):409-12.

Pezzoli G, Canesi M, Galli C. An overview of parkinsonian syndromes: data from the literature and from an Italian data-base. Sleep Med. 2004;5(2): 181-7.

Pillon B, Blin J, Vidailhet M, et al. The neuropsychological pattern of corticobasal degeneration: comparison with progressive supranuclear palsy and Alzheimer’s disease. Neurology. 1995;45(8):1477-83.

Rebeiz JJ, Kolodny EH, Richardson EP, Jr. Corticodentatonigral degeneration with neuronal achromasia. Arch Neurol. 1968;18(1):20-33.

Schneider JA, Watts RL, Gearing M, et al. Corticobasal degeneration: neuropathologic and clinical heterogeneity. Neurology. 1997;48(4):959-69.

Takeda M, Tachibana H, Okuda B, et al. Electrophysiological comparison between corticobasal degeneration and progressive supranuclear palsy. Clin Neurol Neurosurg. 1998;100(2):94-8.

Taniwaki T, Yamada T, Yoshida T, et al. Heterogeneity of glucose metabolism in corticobasal degeneration. J Neurol Sci. 1998;161(1):70-6.

Tashiro K, Ogata K, Goto Y, et al. EEG findings in early-stage corticobasal degeneration and progressive supranuclear palsy: a retrospective study and literature review. Clin Neurophysiol. 2006;117(10):2236-42.

Togaski DM, Tanner CM. Epidemiologic aspects. In: Litvan I, Goetz C, Lang AE, editors. Corticobasal degeneration and related disorders. London: Lippincott Williams and Wilkins;. 2000. pp. 53-60.

Urakami K, Wada K, Arai H, et al. Diagnostic significance of tau protein in cerebrospinal fluid from patients with corticobasal degeneration or progressive supranuclear palsy. J Neurol Sci. 2001;183(1): 95-8.

Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry. 1998;64(2): 84-9.

Titel: 26 Corticobasale degeneratie
Auteurs: J.J. de Vries
K.L. Leenders
Uitgeverij: Bohn Stafleu van Loghum
Boek: Handboek dementie
Print ISBN: 978-90-313-6228-8

Elektronisch ISBN: 978-90-313-8061-9

Copyright: 2009
DOI: https://doi.org/10.1007/978-90-313-8061-9_26

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Kernpunten

Log in om toegang te krijgen